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Simple and rapid spectrophotometric method has been developed and validated for the determination of paroxetine (PRX) in
tablets. The proposed method was based on nucleophilic substitution reaction of PRX with 1,2-naphthoquinone-4-sulphonate
(NQS) in an alkaline medium to form an orange-colored product of maximum absorption peak (λmax) at 488nm. The
stoichiometryandkineticsofthereactionwerestudied,andthereactionmechanismwaspostulated.Undertheoptimizedreaction
conditions, Beer’s law correlating the absorbance (A) with PRX concentration (C) was obeyed in the range of 1–8μgm L
−1.T h e
regression equation for the calibration data was: A = 0.0031 + 0.1609 C, with good correlation coeﬃcients (0.9992). The molar
absorptivity (ε)w a s5 .9×105 Lm o l
−1 1cm −1. The limits of detection and quantitation were 0.3 and 0.8μgm L
−1,r e s p e c t i v e l y .T h e
precision of the method was satisfactory; the values of relative standard deviations did not exceed 2%. The proposed method was
successfully applied to the determination of PRX in its pharmaceutical tablets with good accuracy and precisions; the label claim
percentage was 97.17 ± 1.06%. The results obtained by the proposed method were comparable with those obtained by the oﬃcial
method.
Copyright © 2009 Ibrahim A. Darwish et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
Paroxetine; (3S,4R)-3-[(1,3-benzodioxol-5-vloxy)methyl]-
4-(4-ﬂurophenyl) piperidine (PRX) is a new generation
antidepressant drug. It exerts its antidepressant eﬀect
through a selective inhibition for the reuptake of the
neurotransmitter serotonin by the presynaptic receptors.
PRX is comparable to the tricyclic antidepressants in their
clinical eﬃcacy, however, PRX is safer and has greater
acceptance by the patients [1]. It is also prescribed in the
treatment of related disorders, such as obsessive-compulsive
disorder, panic ﬁts, social phobia, and posttraumatic stress
[2]. PRX is devoid of sedative eﬀect and remarkably safe
in overdose. PRX takes 5.2 hours to reach the peak,
with extended half-life (21 hours) that allowed the
introduction of formulations for once-daily dosing [3].
These combined qualities made PRX the most widely
prescribed antidepressants [4].
The methods reported for quantitative determination of
PRX in tablets and/or biological ﬂuids include voltammetry
[5, 6], densitometry [7, 8], high-performance liquid chro-
matography [9–14], gas chromatography [15–17], and capil-
laryelectrophoresis[18].Thesemethodsoﬀeredtherequired
sensitivityandselectivityfortheanalysisofPRXinbiological
ﬂuids;however,theirsophisticatedinstrumentationandhigh
analysis cost limited their routine use in quality control
laboratories for analysis of PRX in its pharmaceutical tablets.
Spectrophotometry is considered the most convenient
analytical technique because of its inherent simplicity, low
cost, and wide availability in most quality control laborato-
ries. However, few spectrophotometric methods have been
reported for its determination in tablets [19–21]. These2 International Journal of Analytical Chemistry
methods were based on formation of ion-pair associates with
bromophenol blue, bromothymol blue, and bromocresol
green [19], formation of charge-transfer complexes with
7,7,8,8-tetracyanoquinodimethane and chloranilic acid [20],
formation of vinylamino-substituted haloquinone deriva-
tives with haloquinone reagents in presence of acetaldehyde
[21], and formation of condensation product with 7-chloro-
4-nitrobenzofurazon [19]. These methods were associated
with some major drawbacks such as laborious multiple
extraction steps in the analysis by ion pair formation-based
methods [19], and in preparation of the samples for the
analysis by the methods relied on PRX base, rather than
the hydrochloride salt [20, 21]. Furthermore, the analytical
reactions were long and thus the procedures were time-
consuming [19, 21]. For these reasons, the development
of new alternative simple and rapid spectrophotometric
method for the determination of PRX in its tablets was very
essential.
1,2-naphthoquinone-4-sulphonic sulphonate (NQS) has
been used as a chromogenic reagent for the spectropho-
tometric determination of many pharmaceutical amines
[22–26]. However, the reaction between NQS and PRX
has not been investigated so far. The present study
describes the evaluation of NQS as a chromogenic reagent
in the development of simple and rapid spectropho-
tometric method for the determination of PRX in its
tablets.
2. Experimental
2.1.Apparatus. DoublebeamV-530(JASCOCo.Ltd.,Kyoto,
Japan) ultraviolet-visible spectrophotometer with matched
1cm quartz cells was used for all the spectrophotometric
measurements. pH meter, Model 350 (Bibby Scientiﬁc Ltd.,
T/As Jenway, Essex, UK).
2.2. Reagents and Materials. Paroxetine hydrochloride (PRX;
SmithKline Beecham Pharmaceuticals, Bentford, England)
was obtained and used as received; its purity was 99.8 ±
1.45%. A solution of 0.5% (w/v) of 1,2-naphthoquinone-
4-sulphonate (NQS; Aldrich Chemical Co., St. Louis, Mo,
USA) was prepared by dissolving 250mg in 50mL distilled
water. The solution was freshly prepared and protected
from light during use. Clark and Lubs buﬀer solution of
pH 9 was prepared by mixing 50mL of 0.2M aqueous
solution of boric acid and potassium chloride (1 liter
contains 12.368g of boric acid and 14.90g of potassium
chloride)with21.3mLof0.2Msodiumhydroxidein200mL
standard ﬂask [27] and adjusted by pH meter. Seroxate
tablets (SmithKline Beecham Pharmaceuticals, Brentford,
UK) are labeled to contain 20mg paroxetine HCl per tablet.
Double distilled water was obtained through WSC-85 water
puriﬁcation system (Hamilton Laboratory Glass Ltd., Ky,
USA) and used throughout the work. All solvents and
materials used throughout this study were of analytical
grade.
2.3. Preparation of Standard and Sample Solutions
2.3.1. Paroxetine Hydrochloride (PRX) Standard Solution. An
accurately weighed amount (50mg) of PRX was quantita-
tively transferred into a 25mL calibrated ﬂask, dissolved in
20mL distilled water, completed to volume with the same
solvent to obtain a stock solution of 2mgmL−1.T h i ss t o c k
solution was further diluted with water to obtain working
solutions in the range of 10–80μgmL −1.
2.3.2. Tablets Sample Solution. Twenty tablets were weighed
and ﬁnely powdered. An accurately weighed quantity of
the powdered tablets equivalent to 100mg of PRX was
transferred into a 100mL calibrated ﬂask and dissolved in
about 40mL of distilled water. The contents of the ﬂask
were swirled, sonicated for 5 minutes, and then completed
t ov o l u m ew i t hw a t e r .T h ec o n t e n t sw e r em i x e dw e l la n d
ﬁltered rejecting the ﬁrst portion of the ﬁltrate. The prepared
solution was diluted quantitatively with distilled water to
obtain a suitable concentration for the analysis.
2.4. General Recommended Procedure. Accurately measured
aliquots of PRX solution containing 10–50μgmL −1 were
transferred into separate 10mL calibrated ﬂasks. One
milliliter of Clark and Lubs buﬀer solution (pH 9) was added
followed by 1mL of NQS solution (0.5%, w/v). The reaction
solution was allowed to proceed at room temperature (25
± 5◦C) for 10 minutes. The reaction mixture was com-
pleted to volume with methanol, and the resulting solution
was measured at 488nm against reagent blank treated
similarly.
2.5. Determination of the Stoichiometric Ratio of the Reaction
2.5.1. Job’s Method. J o b ’ sm e t h o do fc o n t i n u o u sv a r i a t i o n
[28] was employed. Master equimolar (5 × 10−3 M) aqueous
solutions of PRX and NQS were prepared. Series of 10mL
portions of the master solutions of PRX and NQS were made
up comprising diﬀerent complementary proportions (0 : 10,
1:9 ,..., 9 : 1, 10 : 0, inclusive) in 10mL calibrated ﬂasks
containing 1mL of buﬀer solution (pH 9). The solution was
manipulated as described under the general recommended
procedures, Section 2.4.
2.5.2. Limiting Logarithmic Method. In the limiting logarith-
mic method [29], two sets of experiments were carried out
employing the general recommended procedures described
above. The ﬁrst set of experiments was carried out using
increasing NQS concentrations (1.9 × 10−3 − 9.6 × 10−3 M)
at ﬁxed PRX concentration (1.37 × 10−5 M). The second
set of experiments was carried out using increasing PRX
concentrations (0.3 × 10−5 − 2.04 × 10−5 M) at ﬁxed
NQS concentration (1.92 × 10−2 M). The logarithms of
the obtained absorbances were plotted as function of the
logarithms of the NQS and PRX concentration in the ﬁrst
and second sets of experiments, respectively. The slopes of
the ﬁtting lines in both sets of experiments were calculated.International Journal of Analytical Chemistry 3
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Figure 1: (1) Absorption spectra of PRX against water, (2) NQS
against water, and (3) their reaction product against reagent blank.
3. Results andDiscussion
3.1. Absorption Spectra. According to the procedure, the
absorption spectrum of the product produced by the
reaction between PRX and NQS was recorded (Figure 1).
The product was orange-colored exhibiting a maximum
absorption peak (λmax) at 488nm, and the λmax of NQS was
360nm. The λmax of the product was red-shifted by 248nm
from the λmax of RRX (240nm). In order to eliminate the
interference, the measurements were carried out at 488nm
against the reagent blank.
3.2. Optimization of Reaction Variables
3.2.1. Eﬀect of NQS Concentration. The studying of NQS
concentrations revealed that the reaction was dependent on
NQS reagent (Figure 2). The absorbance of the reaction
solution increased as the NQS concentration increased,
and the highest absorption intensity was attained at NQS
concentration of 0.25% (w/v). Higher NQS concentrations
up to 1.25% had no eﬀect on the absorption values. Further
experiments were carried out using 0.5%.
3.2.2. Eﬀect of Alkalinity and pH. To generate the nucle-
ophile from PRX and activate the nucleophilic substitution
reaction, alkaline medium was necessary. Diﬀerent inorganic
bases were tested: sodium hydroxide, disodium hydrogen
phosphate, and sodium bicarbonate, all prepared as aqueous
solution of a concentration range of 1–25 × 10−3 M.
Best results were obtained in case of sodium hydroxide
where with other bases either precipitation of white colloid
occurred upon diluting the reaction solution with organic
solvent,highblankreadings,nonreproducibleresults,and/or
weak sensitivity were observed. Studies for optimization of
sodium hydroxide concentration revealed that the optimum
concentration was 2–25 × 10−3 M( Figure 2). As well, it was
found that the use of alkaline buﬀer solution gives more
precise readings over the use of NaOH. In a separate series
of experiments, the inﬂuence of pH on the absorbance of
PRX-NQS product was investigated. The results revealed
0
0.4
0.8
1.2
A
b
s
o
r
b
a
n
c
e
00 .511 .5
NQS (%, w/v)
0 5 10 15 20 25 30
NaOH (M×10−3)
Figure 2: Eﬀect of NQS (•) and NaOH (◦) concentrations on the
reaction of PRX with NQS. PRX (40μgmL
−1): 1mL; NaOH: 1mL;
NQS: 1mL; temperature: 25 ± 5◦C; reaction time: 10 minutes.
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Figure 3: Eﬀect of pH on the reaction of PRX with NQS. PRX
(40μgmL
−1): 1mL; Clark and Lubs buﬀe rs o l u t i o n :1 m L ;N Q S
(0.5%, w/v): 1mL; temperature: 25 ± 5◦C; reaction time: 10
minutes.
that the absorbances at pH < 6 were close to 0, indicating
that under acidity, PRX has diﬃculty to react with NQS
(Figure 3). This was possibly due to the fact that the
amino group (piperazinyl-NH) of PRX exists in the form
of hydrochloride amine salt, thus, it loses the nucleophilic
substitution capability. At pH > 6, the absorbance increased
rapidly with the increase in the pH, as the amino group
of PRX turns into the free-NH, rather than the HCl
salt, facilitating the nucleophilic substitution reaction. The
maximum absorption values were attained in the range of
pHat8–10.AtpH>10,theabsorbanceofsolutionobviously
decreased. This was attributed probably to the increase in the
amount of hydroxide ion that holds back the condensation
reaction between PRX and NQS. In order to keep the high
sensibility for determination of PRX, the experiment was
c a r r i e do u ta tp H9 .4 International Journal of Analytical Chemistry
Table 1: Eﬀect of diluting and extracting solvents on the intensity of the reaction product of PRX with NQS.
Diluting solvent Absorbance(a) Extracting solvent Absorbance(a)
Methanol 0.802 Carbon tetrachloride 0.587
Ethanol 0.781 Chloroform 0.808
Isopropanol 0.778 Dichloromethane 0.716
Acetone 0.245 Ethyl acetate 0.362
Acetonitrile 0.686 Toluene 0.267
Dimethylformamide 0.346 Benzene 0.239
1,4-dioxane 0.617
(a)Values for all solvents are mean of three determinations; the RSDs for the readings were <3.
Table 2: Recovery studies for determination of PRX by the proposed method.
Sample number PRX Recovery (% ± SD)(a)
Added (μgmL
−1) Found (μgmL
−1)
(a)
1 2.0 1.99 99.5 ±1.85
2 3.0 2.97 98.9 ±1.20
3 4.0 4.05 101.3 ±0.92
4 5.0 4.88 97.6 ±0.84
5 6.0 5.98 99.7 ±1.50
(a)Values are mean of three determinations.
3.2.3. Eﬀect of Temperature and Time. The eﬀect of tempera-
ture on the reaction was studied by carrying out the reaction
at diﬀerent temperatures (25–90◦C). The results (Figure 4)
revealed that increasing the temperature had negative eﬀect
on the absorption values of the reaction solution. This
was probably attributed to the instability of the PRX-NQS
derivative. For this reason, further experiments were carried
o u ta tr o o mt e m p e r a t u r e( 2 5± 5◦C). The eﬀect of time on
the formation of the reaction product was investigated by
carrying out the reaction for diﬀerent times. The maximum
absorbance intensity was attained after 5 minutes, and
longer reaction time up to 25 minutes did not aﬀect the
absorbance intensity (Figure 4). For more precise results,
further experiments were carried out at 10 minutes.
3.2.4. Eﬀect of Organic Solvents. It was found that the
PRX-NQS product is insoluble in the aqueous reaction
medium. For spectrophotometric measurements, the reac-
tion product might be either dissolved in a miscible
organic solvent of lower polarity than water or extracted
with an immiscible extractive solvent. Diﬀerent solvents
were tested for dilution: methanol, ethanol, isopropanol,
acetone, acetonitrile, dimethylsulphoxide, and 1,4-dioxane.
Thehighestreadingswereobtainedwhenmethanolwasused
for dilution (Table 1). In a separate series of experiments,
diﬀerent nonmiscible solvents were tested for extraction of
the PRX-NQS product: carbon tetrachloride, chloroform,
dichloromethane, ethyl acetate, toluene, and benzene. The
highest readings were obtained when chloroform was used
for extraction. The performance of both extractive and
nonextractive procedures (in terms of sensitivity and back-
ground readings) was comparable. In order to simplify the
analytical procedures, the simple nonextractive procedure
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Figure 4: Eﬀect of temperature (◦) and time (•)o nt h er e a c t i o n
of PRX with NQS. PRX (40μgmL
−1): 1mL; Clark and Lubs buﬀer
solution (pH 9): 1mL; NQS (0.5%, w/v): 1mL.
(dilution with methanol) was chosen as optimum condition
for the further experiments.
3.2.5. Stability of the Chromogen. Under the aforementioned
optimum conditions, the reaction between PRX and NQS
was completed within 5 minutes at room temperature, and
the absorbance no longer changed after standing for up to 25
minutes. The eﬀect of time on the stability of the chromogen
was studied by following the absorption intensity of the
reaction solution (after dilution) at diﬀerent time intervals.
It was found that the absorbance of the chromogen remains
stableforatleast4hours.ThisallowedtheprocessingoflargeInternational Journal of Analytical Chemistry 5
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Figure 5: Job’s plot for determination of stoichiometry of the
reaction between PRX and NQS. [PRX]: 5 × 10
−3 M; [NQS]: 5 ×
10
−3 M; [PRX]+[NQS]: 1mL; Clark and Lubs buﬀer solution (pH
9): 1mL; temperature: 25 ± 5◦C; reaction time: 10 minutes.
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Figure 6: Limiting logarithmic plot for molar reactivity of PRX
with NQS. C and A are the concentration and absorbance,
respectively. For generating the ﬁrst line (), [NQS]: 1.9 × 10
−2;
[PRX]: 0.3 × 10−5 − 2.04 × 10−5 M; Clark and Lubs buﬀer solution
(pH9):1mL;temperature:25 ±5◦C;reactiontime:10minutes.For
generating the second line (•), [NQS]: 1.9 × 10−3 − 1.9 × 10−2 M;
[PRX]: 1.37 × 10−5 M. The other conditions are the same as those
employed in generating the ﬁrst line.
batchesofsamplesandtheircomfortablemeasurementswith
convenience. This increased the convenience of the methods
as well as made it applicable for large number of samples.
3.3. Stoichiometry and Kinetics of the Reaction. Under the
optimum conditions, the stoichiometry of the reaction
b e t w e e nP R Xa n dN Q Sw a si n v e s t i g a t e db yJ o b[ 28]a n d
limiting logarithmic [29] methods. The symmetrical bell
shape of Job’s plot (Figure 5) indicates that the NQS:PRX
ratio was 1 : 1. In the limiting logarithmic method, two
straight lines were obtained (Figure 6) .T h ev a l u e so ft h e
slopes of these lines were 1.0201 and 0.9248, conﬁrming the
1 : 1 ratio for the reaction. Based on this ratio, and the
presence of only one center (piperazinyl N–H group) in PRX
pH = 9
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O
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Figure 7: Scheme for the reaction pathway of PRX with NQS.
Table 3: Analysis of PRX in presence of common excipients by the
proposed method.
Excipient Recovery (% ± SD)(a)
Starch (50)(b) 99.46 ±0.46
Glucose (10) 99.58 ±1.23
Lactose (10) 100.37 ±0.87
Acacia (10) 98.84 ±0.39
Talc (5) 101.53 ±1.02
MS(c)(10) 97.97 ±1.26
Average ± SD 99.63 ±1.23
(a)Values are mean of three determinations.
(b)Figures in parenthesis are the amounts in mg added per 20mg of PRX.
(c)MS: Magnesium stearate.
molecule that is available for the substitution reaction, the
reaction pathway was postulated to be proceeded as shown
in Figure 7.
Under the optimum conditions, the absorbance-time
curves for the reaction of PRX at several concentrations (0.3
× 10−5 − 2.04 × 10−5 M) with a ﬁxed concentration of NQS
(1.9 × 10−2 M) were generated, and the initial reaction rates
(K) were determined from the slopes of the curves. The
logarithms of the reaction rates (LogK) were plotted as a
functionoflogarithmsofPRXconcentration(logC).Asseen
in Figure 8, a straight line passing through the origin with a
slope value of 0.9888 was obtained by ﬁtting the data to the
following equation:
LogK = logK  +nlogC,( 1 )6 International Journal of Analytical Chemistry
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Figure 8:LinearplotforLogC versusLogK forthekineticreaction
of PRX with NQS. C is the PRX concentration (0.3 × 10−5 − 2.04 ×
10−5 M)andK isthereactionrate(second−1).ClarkandLubsbuﬀer
solution (pH 9): 1mL; NQS (1.9 × 10−2): 1mL; temperature: 25 ±
5◦C.
where K is reaction rate, K  is the rate constant, C is the
molar concentration of PRX, and n (slope of regression line)
is the order of the reaction. The value of the slope (≈1)
conﬁrmed that the reaction was ﬁrst order. However, under
theoptimized reactionconditions, theconcentrationofNQS
was in much more excess than that of PRX in the reaction
solution. Therefore, the reaction was regarded as a pseudo-
ﬁrst-order reaction.
3.4. The Apparent Rate Constant and Activation Energy. The
absorbance-time curves at three diﬀerent temperatures (25,
40, and 60◦C) were generated using ﬁxed concentrations
of PRX (1.7 × 10−5 M) and NQS (1.9 × 10−2 M). From
these curves, the apparent rate constants were calculated.
These rates were found to be 6.92 × 10−4,6 . 7× 10−4,a n d
6.25 × 10−4 second−1 at 25, 40, and 60◦C, respectively. The
activation energy, deﬁned as the minimum kinetic energy
that a molecule possess in order to undergo a reaction, was
determined using Arrhenius equation [30]:
Logk = logA −Ea/2.303 RT, (2)
where k is the apparent rate constant, A is the frequency
factor, Ea is the activation energy, T is the absolute tem-
perature, and R is the gas constant. By plotting log k  as a
function of 1/T, a straight line with a slope value of 1.775
= −Ea /2.303 R. From this data, the activation energy was
found to be 8.12kcal mole−1. Because of this low activation
energy, the nucleophilic substitution reaction between PRX
and NQS could be easily taken place, and NQS could be used
for determination of PRX.
3.5. Validation of the Method
3.5.1. Calibration and Sensitivity. Calibration curve for the
determination of PRX by its reaction with NQS was con-
structed by plotting the absorbances as a function of the
corresponding concentrations. The regression equation for
Table 4: Inﬂuence of small variations in the assay conditions on
the analytical performance of the proposed spectrophotometric
method for determination of PRX using NQS reagent.
Parameters Recovery (% ± SD)(a)
Recommended conditions(b) 100.5 ±1.35
NQS concentration (%, w/v)
0.25 98.8 ±0.85
0.75 100.4 ±1.25
Buﬀer solution (pH)
8.8 98.9 ±1.87
9.2 101.5 ±1.67
Reaction time (min)
59 9 .5 ±1.87
15 100.2 ±0.85
(a)Values are mean of 3 determinations.
(b)The recommended conditions are given in Section 2.
the results was A = 0.0031 + 0.1609 C (r = 0.9992), where
A is the absorbance at 488nm, C is the concentration of
PRX in μgmL −1 in the range of 1–8μgmL −1,a n dr is the
correlation coeﬃcient. The molar absorptivity (ε)w a s5 . 9×
105 Lmol −1 cm−1. The limit of detection (LOD) and limit
of quantitation (LOQ) were determined using the formula:
LOD or LOQ = κSDa/b, where κ = 3f o rL O Da n d1 0f o r
LOQ, SDa is the standard deviation of the intercept, and b
is the slope. The LOD and LOQ were 0.3 and 0.8μgmL −1,
respectively. The precision of the proposed method was
determined by analyzing 5 replicate samples of standard
PRX solution at one concentration level. The assay gave
satisfactoryresults;therelativestandarddeviation(RSD)was
less than 2%.
3.5.2. Reproducibility. The reproducibility of the proposed
method was determined by replicate analysis of ﬁve separate
solutions of the working standard at three concentration
levels of each drug (1.5, 3, and 6μgmL −1). The method gave
satisfactory results; RSD did not exceed 2% indicating the
good reproducibility of the proposed method. This precision
level is adequate for the precision and routine analysis of the
investigated drugs in quality control laboratories.
3.5.3. Accuracy and Interference Liabilities. The accuracy of
theproposed method wasevaluatedby thestandard addition
method. The recovery values of the added concentrations
were 97.6 − 101.3 ± 0.84 − 1.85% (Table 2), indicating the
accuracy of the proposed method. Before proceeding with
the analysis of PRX in its tablets, interference liabilities
were carried out to explore the eﬀect of common excipients
that might be added during tablets formulation. Samples
were prepared by mixing known amount (20mg) of PRX
with various amounts of the common excipients: starch,
glucose, lactose, acacia, talc, and magnesium stearate. These
laboratory-prepared samples were analyzed by the proposed
method applying the general recommended procedure. The
recovery values were 97.97 − 101.53 ± 0.39 − 1.26%, with
an average recovery of 99.63 ± 1.23% (Table 3). These dataInternational Journal of Analytical Chemistry 7
Table 5: Analysis of PRX-containing tablets by the proposed and the oﬃcial methods.
Tablet Recovery (% ± RSD)(a)
t-value(c) F-value(c)
Proposed Oﬃcial(b)
Seroxate tablets 99.17 ±1.06 101.31 ±0.48 2.20 4.88
(a)Values are mean of 6 determinations.
(b)Reference [14].
(c)The tabulated values of t-a n dF-values at 95% conﬁdence limit are 2.78 and 6.39, respectively.
conﬁrmed the absence of interference from any of the
common excipients with the determination of PRX by the
proposed method.
3.5.4. Robustness and Ruggedness. Robustness was examined
by evaluating the inﬂuence of small variation of method
variables including concentration of analytical reagent and
reaction time on the performance of the proposed methods.
In these experiments, one parameter was changed whereas
the others were kept unchanged, and the recovery percentage
was calculated each time. It was found that small variation of
method variables did not signiﬁcantly aﬀect the procedures;
recovery values were 98.8 − 101.5 ±0.85 − 1.87% (Table 4).
Thisprovidedanindicationforthereliabilityoftheproposed
method during its routine application for the analysis of
PRX. Ruggedness was also tested by applying the proposed
methods to the assay of PRX using the same operational
conditions but using two diﬀerent instruments at two
diﬀerent laboratories and diﬀerent elapsed time. Results
obtained from lab-to-lab and day-to-day variations were
reproducible, as the relative standard deviations (RSDs) did
not exceed 2.54%.
3.6. Application of the Proposed Method to Analysis of PRX in
Tablets. It is evident from the above-mentioned results that
the proposed method gave satisfactory results with PRX in
bulk. Thus, its tablets were subjected to the analysis of their
PRX contents by the proposed and the oﬃcial [14] methods.
The label-claim percentagewas99.17±1.06% (Table 5).This
result was compared with that obtained from the oﬃcial
methodbystatisticalanalysiswithrespecttotheaccuracy(by
t-test) and precision (by F-test). No signiﬁcant diﬀerences
were found between the calculated and theoretical values
of t-a n dF-tests at 95% conﬁdence level proving similar
accuracy and precision in the determination of PRX by both
methods.
4. Conclusions
The present study described the successful evaluation of
NQS reagent in the development of simple and rapid
spectrophotometric method for the accurate determination
of PRX in bulk and tablets. In contrast with the previously
reported methods for analysis of PRX, the method described
herein has many advantages: it does not need expensive
sophisticated apparatus, it is simple and rapid, and it has
high sensitivity. Furthermore, all the analytical reagents are
inexpensive, have excellent shelf life, and are available in any
analytical laboratory. Therefore, this method is practical and
valuable for its routine application in the analysis of PRX in
quality control laboratories.
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